Showing results (241-250 of 335) with videos related to

Sort By:
Pageof 34
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2013
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settingsT M A Abdel-Fatah, C Perry, P Dickinson, et al.
British Journal of Cancer|March 1, 1991
c-erbB-2 oncoprotein expression in primary and advanced breast cancerC Lovekin, I O Ellis, A Locker, et al.
Histopathology|February 26, 2000
Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five casesH Denley, S E Pinder, P H Tan, et al.
Cancer Research|April 1, 1994
Transforming growth factor-alpha and endocrine sensitivity in breast cancerR I Nicholson, R A McClelland, J M Gee, et al.
Clinical Radiology|August 1, 1996
The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancersJ C Litherland, A J Evans, A R Wilson, et al.
Breast Cancer Research and Treatment|January 1, 1994
Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapyR I Nicholson, R A McClelland, J M Gee, et al.
British Journal of Cancer|July 4, 1998
Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapyR A McClelland, D L Manning, J M Gee, et al.
Pageof 34